This report aims to provide a comprehensive presentation of the global market for Brain Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Diagnostics. This report contains market size and forecasts of Brain Cancer Diagnostics in global, including the following market information:
Global Brain Cancer Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Brain Cancer Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Imaging Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Brain Cancer Diagnostics include Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems and Hitachi, Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Brain Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Cancer Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Brain Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Imaging Test
Lumbar Puncture
Biopsy
Molecular Testing
Others
Global Brain Cancer Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Brain Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Others
Global Brain Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Brain Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Brain Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
GE Healthcare
MDxHealth
NantOmics
Biocept, Inc.
Koninklijke Philips N.V.
Canon Medical Systems
Hitachi, Ltd.
Neusoft Medical Systems
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brain Cancer Diagnostics, market overview.
Chapter 2: Global Brain Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Brain Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brain Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brain Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Cancer Diagnostics Overall Market Size
2.1 Global Brain Cancer Diagnostics Market Size: 2022 VS 2030
2.2 Global Brain Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Cancer Diagnostics Players in Global Market
3.2 Top Global Brain Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Brain Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Brain Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Brain Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Brain Cancer Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Imaging Test
4.1.3 Lumbar Puncture
4.1.4 Biopsy
4.1.5 Molecular Testing
4.1.6 Others
4.2 By Type - Global Brain Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Brain Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Brain Cancer Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Cancer Diagnostics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 By Application - Global Brain Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Brain Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Brain Cancer Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Brain Cancer Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Brain Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Brain Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Brain Cancer Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Brain Cancer Diagnostics Revenue, 2018-2030
6.3.2 US Brain Cancer Diagnostics Market Size, 2018-2030
6.3.3 Canada Brain Cancer Diagnostics Market Size, 2018-2030
6.3.4 Mexico Brain Cancer Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Brain Cancer Diagnostics Revenue, 2018-2030
6.4.2 Germany Brain Cancer Diagnostics Market Size, 2018-2030
6.4.3 France Brain Cancer Diagnostics Market Size, 2018-2030
6.4.4 U.K. Brain Cancer Diagnostics Market Size, 2018-2030
6.4.5 Italy Brain Cancer Diagnostics Market Size, 2018-2030
6.4.6 Russia Brain Cancer Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Brain Cancer Diagnostics Market Size, 2018-2030
6.4.8 Benelux Brain Cancer Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Brain Cancer Diagnostics Revenue, 2018-2030
6.5.2 China Brain Cancer Diagnostics Market Size, 2018-2030
6.5.3 Japan Brain Cancer Diagnostics Market Size, 2018-2030
6.5.4 South Korea Brain Cancer Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Brain Cancer Diagnostics Market Size, 2018-2030
6.5.6 India Brain Cancer Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Brain Cancer Diagnostics Revenue, 2018-2030
6.6.2 Brazil Brain Cancer Diagnostics Market Size, 2018-2030
6.6.3 Argentina Brain Cancer Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Cancer Diagnostics Revenue, 2018-2030
6.7.2 Turkey Brain Cancer Diagnostics Market Size, 2018-2030
6.7.3 Israel Brain Cancer Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Brain Cancer Diagnostics Market Size, 2018-2030
6.7.5 UAE Brain Cancer Diagnostics Market Size, 2018-2030
7 Brain Cancer Diagnostics Companies Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Company Summary
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Major Product Offerings
7.1.4 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.2 Siemens Healthineers AG
7.2.1 Siemens Healthineers AG Company Summary
7.2.2 Siemens Healthineers AG Business Overview
7.2.3 Siemens Healthineers AG Brain Cancer Diagnostics Major Product Offerings
7.2.4 Siemens Healthineers AG Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Siemens Healthineers AG Key News & Latest Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Company Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Brain Cancer Diagnostics Major Product Offerings
7.3.4 GE Healthcare Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 GE Healthcare Key News & Latest Developments
7.4 MDxHealth
7.4.1 MDxHealth Company Summary
7.4.2 MDxHealth Business Overview
7.4.3 MDxHealth Brain Cancer Diagnostics Major Product Offerings
7.4.4 MDxHealth Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 MDxHealth Key News & Latest Developments
7.5 NantOmics
7.5.1 NantOmics Company Summary
7.5.2 NantOmics Business Overview
7.5.3 NantOmics Brain Cancer Diagnostics Major Product Offerings
7.5.4 NantOmics Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 NantOmics Key News & Latest Developments
7.6 Biocept, Inc.
7.6.1 Biocept, Inc. Company Summary
7.6.2 Biocept, Inc. Business Overview
7.6.3 Biocept, Inc. Brain Cancer Diagnostics Major Product Offerings
7.6.4 Biocept, Inc. Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Biocept, Inc. Key News & Latest Developments
7.7 Koninklijke Philips N.V.
7.7.1 Koninklijke Philips N.V. Company Summary
7.7.2 Koninklijke Philips N.V. Business Overview
7.7.3 Koninklijke Philips N.V. Brain Cancer Diagnostics Major Product Offerings
7.7.4 Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Koninklijke Philips N.V. Key News & Latest Developments
7.8 Canon Medical Systems
7.8.1 Canon Medical Systems Company Summary
7.8.2 Canon Medical Systems Business Overview
7.8.3 Canon Medical Systems Brain Cancer Diagnostics Major Product Offerings
7.8.4 Canon Medical Systems Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Canon Medical Systems Key News & Latest Developments
7.9 Hitachi, Ltd.
7.9.1 Hitachi, Ltd. Company Summary
7.9.2 Hitachi, Ltd. Business Overview
7.9.3 Hitachi, Ltd. Brain Cancer Diagnostics Major Product Offerings
7.9.4 Hitachi, Ltd. Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Hitachi, Ltd. Key News & Latest Developments
7.10 Neusoft Medical Systems
7.10.1 Neusoft Medical Systems Company Summary
7.10.2 Neusoft Medical Systems Business Overview
7.10.3 Neusoft Medical Systems Brain Cancer Diagnostics Major Product Offerings
7.10.4 Neusoft Medical Systems Brain Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Neusoft Medical Systems Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Brain Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Brain Cancer Diagnostics Market Drivers in Global Market
Table 3. Brain Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Brain Cancer Diagnostics in Global Market
Table 5. Top Brain Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Brain Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Brain Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Brain Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Brain Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Brain Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Brain Cancer Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Brain Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Brain Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Brain Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Brain Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Brain Cancer Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Thermo Fisher Scientific Inc. Company Summary
Table 31. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Product Offerings
Table 32. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 34. Siemens Healthineers AG Company Summary
Table 35. Siemens Healthineers AG Brain Cancer Diagnostics Product Offerings
Table 36. Siemens Healthineers AG Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Siemens Healthineers AG Key News & Latest Developments
Table 38. GE Healthcare Company Summary
Table 39. GE Healthcare Brain Cancer Diagnostics Product Offerings
Table 40. GE Healthcare Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. GE Healthcare Key News & Latest Developments
Table 42. MDxHealth Company Summary
Table 43. MDxHealth Brain Cancer Diagnostics Product Offerings
Table 44. MDxHealth Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. MDxHealth Key News & Latest Developments
Table 46. NantOmics Company Summary
Table 47. NantOmics Brain Cancer Diagnostics Product Offerings
Table 48. NantOmics Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. NantOmics Key News & Latest Developments
Table 50. Biocept, Inc. Company Summary
Table 51. Biocept, Inc. Brain Cancer Diagnostics Product Offerings
Table 52. Biocept, Inc. Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Biocept, Inc. Key News & Latest Developments
Table 54. Koninklijke Philips N.V. Company Summary
Table 55. Koninklijke Philips N.V. Brain Cancer Diagnostics Product Offerings
Table 56. Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Koninklijke Philips N.V. Key News & Latest Developments
Table 58. Canon Medical Systems Company Summary
Table 59. Canon Medical Systems Brain Cancer Diagnostics Product Offerings
Table 60. Canon Medical Systems Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Canon Medical Systems Key News & Latest Developments
Table 62. Hitachi, Ltd. Company Summary
Table 63. Hitachi, Ltd. Brain Cancer Diagnostics Product Offerings
Table 64. Hitachi, Ltd. Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Hitachi, Ltd. Key News & Latest Developments
Table 66. Neusoft Medical Systems Company Summary
Table 67. Neusoft Medical Systems Brain Cancer Diagnostics Product Offerings
Table 68. Neusoft Medical Systems Brain Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Neusoft Medical Systems Key News & Latest Developments
List of Figures
Figure 1. Brain Cancer Diagnostics Segment by Type in 2022
Figure 2. Brain Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Brain Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brain Cancer Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Brain Cancer Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Brain Cancer Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Brain Cancer Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Siemens Healthineers AG Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GE Healthcare Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. MDxHealth Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. NantOmics Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biocept, Inc. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Canon Medical Systems Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hitachi, Ltd. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Neusoft Medical Systems Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
